Management of primary and metastatic liver cancer presents a complex challenge to oncologists, hepatologists and multidisciplinary treatment teams.
Selective internal radiation therapy (SIRT) with SIR-Spheres® Y-90 resin microspheres is an approved local therapy for the treatment of patients with advanced non-operable liver tumours with proven evidence and ongoing clinical research:
- Recent data from an array of large, multi-centre, international studies support expanded use of SIR-Spheres Y-90 resin microspheres in appropriate patients with metastatic colorectal cancer (mCRC) and Hepatocellular Carcinoma (HCC).
- Sirtex is supporting a clinical research program to further investigate and expand the use of SIR-Spheres Y-90 resin microspheres.